J&J Wins EU Nod For Akeega To Go Up Against AZ/MSD’s Lynparza In First-Line mCRPC

With BRCA-Mutated Niche

 
• By Ayisha Sharma
  
Lots of yellow squares, one white circle shaded in, representing niche
Akeega's Strong Efficacy In BRCA-Mutated Patients Carves A Niche • Source: Shutterock

More from New Products

More from Scrip